Swedencare AB
Industry Group: Pharmaceuticals
Country/Region: Sweden
Identifier: OME:SECARE
Swedencare AB specializes in pet healthcare. It develops, manufactures partly in its factories, markets, and sells products in the fast-growing market of healthcare products for cats, dogs, and horses. The group has an extensive portfolio of brands and products in various therapy areas, including Animal Pharmaceuticals, Nutravet, NutriScience, Pet MD, Stratford, VetWELL, ProDen PlaqueOff, Rx Vitamins, Riley’s, NaturVet, Pet Organics, Overby Farm, Vet Classics, and Innovet’s brands. Its products are sold to veterinarians, pet stores, and online through a distribution network comprising various subsidiaries and an international network of retailers. The group's operating segments include North America, which generates maximum revenue, Europe, and Production.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Pharmaceuticals 228 out of 844
Universe
Global Universe 7890 out of 14652
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the non-India based rated subjects, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
| Company | ESG Risk Rating | Industry Rank |
|---|---|---|
| Swedencare AB |
26.5
Medium
|
228 out of 844 |
| Great Tree Pharmacy Co., Ltd. |
34.2
High
|
574 out of 844 |
| Luoxin Pharmaceuticals Group Stock Co., Ltd. |
34.3
High
|
576 out of 844 |
| Shandong Sinobioway Biomedicine Co., Ltd. |
36.3
High
|
674 out of 844 |
| Shanghai Hile Bio-Technology Co., Ltd. |
38.4
High
|
757 out of 844 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.